Real-time glucose sensors in children and adolescents with type-1 diabetes

Hormone Research

Volumn 70, Issue 4, 2008, Pages 193-202

  Danne, Thomas ^a,b   Lange, Karin ^a   Kordonouri, Olga ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KINDERKRANKENHAUS AUF DER BULT   (Germany)

Author keywords

Diabetes therapy; Glucose sensors, real time

Indexed keywords

GLUCOSE;

BLOOD GLUCOSE MONITORING; FEEDBACK SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSDUCER; HOLTER MONITORING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICRODIALYSIS; PATIENT SATISFACTION; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF MONITORING; SENSOR; SHORT SURVEY; SOCIAL PSYCHOLOGY;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN INFUSION SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 50849090588     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151592     Document Type: Short Survey

References (64)

1. The effect of intensive diabetes treatment on the development and progression of longterm complications in adolescents with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994;125:177-188.
2. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001;139:804-812.
3. Diabetes Research in Children Network (DirecNet) Study Group, Wilson DM, Kollman C: Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high frequency glucose determinations by sensors. Diabetes Care 2008;31:381-385.
4. Heller S, Kim H, Draeger E: Within-person variation in fasting blood glucose is correlated to incidence of hypoglycemia in people with type 1 diabetes treated with insulin detemir and NPH insulin. Diabetologia 2004;47S1:A303.
5. Service FJ, Molnar GD, Rosevear JW, Ackermann E, Gatweood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
6. Saudek CD, Derr RL, Kalyani RR: Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006;295:1688-1697.
7. Danne T, Lange K, Kordonouri O: New developments in the treatment of type 1 diabetes in children. Arch Dis Child 2007;92:1015-1019.
8. Brownlee M, Hirsch IB: Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006;295:1707-1708.
9. Alemzadeh R, Loppnow C, Parton E, Kirby M: Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 2003;5:167-173.
10. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955-962.
11. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56.
12. Potts RO, Tamada JA, Tierney MJ: Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 2002;18(suppl 1):S49-S53.
13. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther 2004;6:105-113.
14. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347-352.
15. Pfuetzner A, Caduff A, Larbig M, Schrepfer T, Forst T: Impact of posture and fixation technique on impedance spectroscopy used for continuous and non-invasive glucose monitoring. Diabetes Technol Ther 2004;6:435-441.
16. Feldman B, Brazg R, Schwartz S, Weinstein R: A continuous glucose sensor based on wired enzyme technology: results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003;5:769-779.
17. Bailey TS, Zisser HC, Garg SK: Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007;9:203-210.
18. Wentholt IM, Hoekstra JB, Zwart A, DeVries JH: Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia 2005;48:1055-1058.
19. Klonoff DC: Noninvasive blood glucose monitoring. Diabetes Care 1997;20:433-437.
20. Pickup J, McCartney L, Rolinski L, Birch D: In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring. Interview by Judy Jones. BMJ 1999;319:1289-1293.
21. Heinemann L, Schmelzeisen-Redeker G: Non-invasive continuous glucose monitoring in type I diabetic patients with optical glucose sensors. Non-Invasive Task Force (NITF). Diabetologia 1998;41:848-854.
22. Gabriely I, Wozniak R, Mevorach M, Kaplan J, Aharon Y, Shamoon H: Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care 1999;22:2026-2032.
23. Robinson MR, Eaton RP, Haaland DM, et al: Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. Clin Chem 1992;38:1618-1622.
24. Heise HM, Lampen P: Transcutaneous glucose measurement using near-infrared spectroscopy: validation of statistical calibration models. Diabetes Care 2000;23:1208-1210.
25. Kost J, Mitragotri S, Gabbay RA, Pishko M, Langer R: Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med 2000;6:347-350.
26. Quan KM, Christison GB, Mackenzie HA, Hodgson P: Glucose determination by a pulsed photoacoustic technique: an experimental study using a gelatin-based tissue phantom. Phys Med Biol 1993;38:1911-1922.
27. Tamada JA, Garg SK, Jovanovic L, Pitzer KR, Fermi SJ, Potts RO: Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA 1999;282:1839-1844.
28. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP: Correlation of finger-stick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 1999;22:1708-1714.
29. Chase HP, Beck R, Tamborlane W, et al: A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005;28:1101-1106.
30. Tsalikian E, Kollman C, Mauras N, Weinzimer S, Buckingham B, Xing D, Beck R, Ruedy K, Tamborlane W, Fiallo-Scharer R; Diabetes Research in Children Network (DirecNet) Study Group: GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technol Ther 2004;6:559-565.
31. Bolinder J, Ungerstedt U, Arner P: Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet 1993;342:1080-1085.
32. Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P: Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997;20:64-70.
33. Hashiguchi Y, Sakakida M, Nishida K, Uemura T, Kajiwara K, Shichiri M: Development of miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method. Diabetes Care 1994;17:387-396.
34. Mastrototaro JJ: The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2000;2(suppl 1):s13-s18.
35. Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ; The Diabetes Research in Children Network (DirecNet) Study Group: Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther 2005;7:109-114.
36. Weintrob N, Schechter A, Benzaquen H, et al: Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs. continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med 2004;158:677-684.
37. Golicki DT, Golicka D, Groele L, Pankowska E: Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2008;51:233-240.
38. Yates K, Hasnat Milton A, Dear K, Ambler G: Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care 2006;29:1512-1517.
39. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS: Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006;7:159-164.
40. Deiss D, Hartmann R, Schmidt J, Kordonouri O: Results of an randomized controlled cross-over-trial on the effect of continuous glucose monitoring (CGMS) on glycemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2006;114:63-67.
41. Ludvigsson J, Hanas R: Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled cross-over study. Pediatrics 2003;11:933-938.
42. Chase HP, Kim LM, Owen SL, et al: Continuous glucose monitoring in children with type 1 diabetes. Pediatrics 2001;107:222-226.
43. Gandrud LM, Xing D, Kollman C, Block JM, Kunselman B, Wilson DM, Buckingham BA: The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Ther 2007;9:307-316.
44. Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J: Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes Technol Ther 2007;9:339-347.
45. Wiltshire EJ, Newton K, McTavish L: Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors. J Paediatr Child Health 2006;42:758-763.
46. Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T: Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes. Pediatr Diabetes 2007;8:157-162.
47. McDonnell CM, Northam EA, Donath SM, Werther GA, Cameron FJ: Hyperglycemia and externalizing behavior in children with type 1 diabetes. Diabetes Care 2007;30:2211-2215.
48. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
49. Tubiana-Rufi N, Riveline JP, Dardari D: Real-time continuous glucose monitoring using GuardianRT: from research to clinical practice. Diabetes Metab 2007;33:415-420.
50. Halvorson M, Carpenter S, Kaiserman K, Kaufman F: A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump. J Pediatr 2007;150:103-105.
51. Danne T, Liebl A, Reicherl A, Walte K, Bacher F, Röthig K, Lauterborn R, Kordonouri O: First user experience with an integrated insulin pump and real-time continuous glucose monitoring system in pediatric and young adult patients with type 1 diabetes. Pediatr Diabetes 2006;7(suppl 5):65.
52. Wilson DM, Beck RW, Tamborlane WV, Dontchev MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzimer SA; DirecNet Study Group: The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007;30:59-64.
53. Diabetes Research in Children Network (DirecNet) Study Group, Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T: Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007;151:388-393, 393.e1-e2.
54. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group: FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care 2008;31:525-527.
55. Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M: Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 2001;24:863-869.
56. Piper HG, Alexander JL, Shukla A, Pigula F, Costello JM, Laussen PC, Jaksic T, Agus MS: Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics 2006;118:1176-1184.
57. Diabetes Research In Children Network (Direcnet) Study Group, Buckingham BA, Kollman C, Beck R, Kalajian A, Fiallo-Scharer R, Tansey MJ, Fox LA, Wilson DM, Weinzimer SA, Ruedy KJ, Tamborlane WV: Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006;8:318-325.
58. Diabetes Research in Children Network (DirecNet) Study Group: Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes 2006;7:32-38.
59. Buckingham B, Halvorson M, Kunselman E, Kaufmann FR: Sensor augmented pump therapy in adolescents: results of the first treat-to-target study. Diabetes 2007;56(suppl 1):A 479.
60. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK: A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000;23:208-214.
61. Renard E: Implantable closed-loop glucosesensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2002;2:708-716.
62. Hovorka R, Chassin LJ, Wilinska ME: Closing the loop: the ADICOL experience. Diabetes Technol Ther 2004;6:307-318.
63. Dassau E, Bequette BW, Buckingham BA, Doyle FJ: Detection of a meal using continuous glucose monitoring (CGM): implications for an artificial beta-cell. Diabetes Care 2008;31:295-300.
64. Klonoff DC: Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005;28:1231-1239.